Jarden’s continued success drives evolving strategy & structure
Reaching our goal three years ahead of target In 2016, Jarden set the ambitious goal of quadrupling the business by 2026.
News & insights
Analysis: What should investors be looking out for in healthcare sector growth exposures?
Across Australia and New Zealand there are a number of large capitalisation healthcare companies that have delivered strong and consistent valuation growth over the last ten years including Fisher &…